United States — Food and Drug Administration & Zoetis

United States — Food and Drug Administration: The United States — Food and Drug Administration issued safety warnings concerning serious neurological complications in dogs treated with Bedinvetmab, which contributed to weakening prescription growth for Zoetis' product.

Zoetis: Zoetis is the defendant in multiple class action lawsuits alleging securities fraud due to misleading statements about its product performance and market share. The company's stock price has fallen significantly following disclosures of weakening demand and increased competition for its key companion animal products.

United States — Food and Drug Administration: The United States — Food and Drug Administration>>> granted emergency use authorization for several drugs to treat screwworm, aiding in the response to the outbreak.

Zoetis: Zoetis>>> shares also rose, benefiting from the potential increased spending on livestock drugs if the screwworm outbreak necessitates widespread treatment.